Larry W. Kwak

Also affiliated with University of California, Irvine, City of Hope

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE”.

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Blood(2022)10.1182/blood.2022015423

N/A

3.0DataRank · unranked

121 citations

Hun Ju Lee, Joycelynne Palmer, Robert Chen, Ni‐Chun Tsai, Lu Chen +18 more

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

The Lancet Haematology(2022)10.1016/s2352-3026(22)00318-0

N/A

1.4DataRank · unranked

41 citations

Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei +20 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485

N/A

1.3DataRank · unranked

40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study

The Lancet Haematology(2024)10.1016/s2352-3026(24)00171-6

N/A

0.673DataRank · unranked

20 citations

Jasmine Zain, Kerry J. Savage, Tatyana Feldman, Jonathan E. Brammer, Lu Chen +14 more

Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma

Haematologica(2023)10.3324/haematol.2023.283002

N/A

0.599DataRank · unranked

19 citations

Matthew Mei, Lu Chen, Joo Y. Song, Victoria Bedell, Elizabeth Budde +13 more

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies

Blood Advances(2024)10.1182/bloodadvances.2024013195

N/A

0.176DataRank · unranked

2 citations

Lihua E. Budde, Elizabeth Oh, Szymon J. Szymura, Aaron Anderson, Marissa Morales Del Real +5 more

Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies

Blood Advances(2022)10.1182/bloodadvances.2022008560

N/A

0DataRank · unranked

6 citations

Joo Y. Song, Elana Thieme, Aaron Anderson, Elizabeth Oh, Wesley A. Cheng +16 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309

N/A

0DataRank · unranked

0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309.v1

N/A

0DataRank · unranked

0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.01.551552

N/A

0DataRank · unranked

0 citations

Zhuoran Zhang, Dongfang Wang, S. Bhattacharya, Marice Alcantara, Yong Liang +6 more

First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma

Research Square(2023)10.21203/rs.3.rs-3315017/v1

N/A

0DataRank · unranked

0 citations

Szymon J. Szymura, Lin Wang, Tiantian Zhang, Soung-chul Cha, Zhenyuan Dong +13 more

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102137

N/A

0DataRank · unranked

32 citations

Zhuoran Zhang, S. Bhattacharya, Dongfang Wang, Marice Alcantara, Liang Yong +6 more

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial

Nature Communications(2024)10.1038/s41467-024-50880-2

N/A

0DataRank · unranked

18 citations

Lin Wang, Tiantian Zhang, Soung-chul Cha, Joo Y. Song, Zhenyuan Dong +14 more

Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study

UNC Libraries(2024)10.17615/yf5z-nb94

N/A

0DataRank · unranked

0 citations

Joe Coresh, A.R Folsom, D Wang, C.E Ndumele, Vijay Nambi +10 more

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma

HemaSphere(2025)10.1002/hem3.70126

N/A

0DataRank · unranked

8 citations

Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai +13 more

Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02614-8

N/A

0DataRank · unranked

20 citations

Wesley A. Cheng, D. Lynne Smith, Brian Z. Huang, Tiantian Zhang, Wen-Chung Chang +5 more

Cell-selective telomere damage by thiopurine-based oligonucleotide for diffuse large B cell lymphoma immunotherapy

Molecular Therapy(2025)10.1016/j.ymthe.2025.07.029

N/A

0DataRank · unranked

0 citations

Elaine Kang, Dongfang Wang, Yong Liang, Piotr Swiderski, Feng Ye +6 more

Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.026

N/A

0DataRank · unranked

14 citations

Xingli Zhao, Dongfang Wang, Dayson Moreira, Yu‐Lin Su, Marice Alcantara +7 more

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0236

N/A

0DataRank · unranked

46 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

The changing investment in translational science by academic medical centers: HOPE in the Valley of Death

Journal of Clinical Investigation(2020)10.1172/jci138640

N/A

0DataRank · unranked

5 citations

Steven T. Rosen, Larry W. Kwak, Lucy Ghoda

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2378

N/A

0DataRank · unranked

43 citations

Anamarija M. Perry, Alex F. Herrera, Lu Chen, Pamela Skrabek, Michel R. Nasr +19 more

Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events

The Lancet Haematology(2021)10.1016/s2352-3026(21)00378-1

N/A

0DataRank · unranked

12 citations

Krishna Gundabolu, Larry W. Kwak, Benjamin Djulbegović, Oscar Champigneulle, Brian D. Josephson +3 more